DIP
WST icon

DT Investment Partners’s West Pharmaceutical WST Stock Holding History

DT Investment Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-41
Closed -$9.18K – 555
2025
Q1 		$9.18K Hold
41
– – ﹤0.01% 420
2024
Q4 		$13.4K Hold
41
– – ﹤0.01% 373
2024
Q3 		$12.3K Hold
41
– – ﹤0.01% 419
2024
Q2 		$13.5K Hold
41
– – ﹤0.01% 353
2024
Q1 		$16.2K Hold
41
– – ﹤0.01% 304
2023
Q4 		$15.4K Hold
41
– – ﹤0.01% 296
2023
Q3 		$15.4K Hold
41
– – ﹤0.01% 278
2023
Q2 		$15.2K Hold
41
– – ﹤0.01% 287
2023
Q1 		$15K Hold
41
– – ﹤0.01% 283
2022
Q4 		$9.65K Hold
41
– – ﹤0.01% 332
2022
Q3 		$10K Buy
+41
New +$12.5K ﹤0.01% 306

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return